🇦🇪 Blujepa in United Arab Emirates

Blujepa (GEPOTIDACIN) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Marketing authorisation holder: GLAXOSMITHKLINE
  • Status: likely_approved

Blujepa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United Arab Emirates

Frequently asked questions

Is Blujepa approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Blujepa in United Arab Emirates?

GLAXOSMITHKLINE holds the UAE marketing authorisation.